Field Epidemiology Training Program

Similar documents
Swindon Joint Strategic Needs Assessment Bulletin

Breast Cancer Awareness Month 2018 Key Messages (as of June 6, 2018)

Lyme Disease Surveillance in North Carolina

The estimator, X, is unbiased and, if one assumes that the variance of X7 is constant from week to week, then the variance of X7 is given by

ACRIN 6666 Screening Breast US Follow-up Assessment Form

insights2017 QLD Kids Helpline Statistical Summary Queensland Insights into young people in Australia

HEALTH SURVEILLANCE INDICATORS: CERVICAL CANCER SCREENING. Public Health Relevance. Highlights.

DATA RELEASE: UPDATED PRELIMINARY ANALYSIS ON 2016 HEALTH & LIFESTYLE SURVEY ELECTRONIC CIGARETTE QUESTIONS

Nonclinical factors associated with premature termination of adjuvant chemotherapy for stage I-III breast cancer

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

Human papillomavirus (HPV) refers to a group of more than 150 related viruses.

EXPLORING THE PROCESS OF ASSESSMENT AND OTHER RELATED CONCEPTS

WHAT IS HEAD AND NECK CANCER FACT SHEET

Volume Measurement at CT

(Please text me on once you have submitted your request online and the cell number you used)

Chapter 6: Impact Indicators

A pre-conference should include the following: an introduction, a discussion based on the review of lesson materials, and a summary of next steps.

Rate Lock Policy. Contents

2. How are screening and diagnostic mammograms different?

CDC Influenza Division Key Points MMWR Updates February 20, 2014

LTCH QUALITY REPORTING PROGRAM

Completing the NPA online Patient Safety Incident Report form: 2016

2017 CMS Web Interface

BRCA1 and BRCA2 Mutations

NPCR CLINICAL EDIT CHECKS

PHARYNGO-OESOPHAGECTOMY

Frequently Asked Questions: IS RT-Q-PCR Testing

SUBSPECIALIST TRAINING PROGRAMME in GYNAECOLOGICAL ONCOLOGY

The data refer to persons aged between 15 and 54.

AP Biology Lab 12: Introduction to the Scientific Method and Animal Behavior

Introduction. Lesson developed by: Heather Medema-Johnson, M.S, ATC, CSCS

Assessment Field Activity Collaborative Assessment, Planning, and Support: Safety and Risk in Teams

Improving Surveillance and Monitoring of Self-harm in Irish Prisons

Session78-P.doc College Adjustment And Sense Of Belonging Of First-Year Students: A Comparison Of Learning Community And Traditional Students

Cardiac Rehabilitation Services

A Unified Approach to Conflict Mineral Compliance for the Tungsten Industry. The Westin, Sydney, 23 September 2013

Annual Principal Investigator Worksheet About Local Context

2018 Medical Association Poster Symposium Guidelines

NIA Magellan 1 Spine Care Program Interventional Pain Management Frequently Asked Questions (FAQs) For Medicare Advantage HMO and PPO

The principles of evidence-based medicine

FDA Dietary Supplement cgmp

Hospital Preparedness Checklist

Recommendations for Risk Management at Swine Exhibitions and for Show Pigs August 2012

FOUNDATIONS OF DECISION-MAKING...

Interpretation. Historical enquiry religious diversity

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

Implementation of G6PD testing and radical cure in P. vivax endemic countries: considerations

Dental Benefits. Under the TeamstersCare Plan, you and your eligible dependents have three basic options when you need dental care.

Cancer Association of South Africa (CANSA)

A fake medicine that passes itself off as a real, authorised medicine. (1)

CHAPTER 2. HEALTH SERVICES

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

Structured Assessment using Multiple Patient. Scenarios (StAMPS) Exam Information

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

Key Points Enterovirus D68 in the United States, 2014 Note: Newly added information is in red.

PMI End Use Verification (EUV) Survey Uganda 31 May 2016

Lee County Florida Income Guideline Chart

QUALITY AND SAFETY MEASURES UPDATE January 2016

Percutaneous Nephrolithotomy (PCNL)

Coding. Training Guide

This information shows what new challenges are likely to require prevention efforts moving forward.

PROCEDURAL SAFEGUARDS NOTICE PARENTAL RIGHTS FOR PRIVATE SCHOOL SPECIAL EDUCATION STUDENTS

Campus Climate Survey

Advance Care Planning Collaboration 101

Obesity/Morbid Obesity/BMI

If, then. Homework: Finish entire guided notes packet. Name: Pod: Date: Which variable does a scientist manipulate or control in an experiment?

Health Screening Record: Entry Level Due: August 1st MWF 150 Entry Year


National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Louisiana Healthcare Connections Providers

Male patients with pain, swelling or erythema please refer to the Acute Painful Scrotum pathway Female patients

Podcast Transcript Title: Common Miscoding of LARC Services Impacting Revenue Speaker Name: Ann Finn Duration: 00:16:10

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQs) For Managed Health Services (MHS)

Osteoporosis Fast Facts

DISCUSSION DRAFT DEVENTER, OCTOBER 2006 Consolidation of documents due for revision

Q 5: Is relaxation training better (more effective than/as safe as) than treatment as usual in adults with depressive episode/disorder?

Vaccine Information Statement: PNEUMOCOCCAL CONJUGATE VACCINE

SUMMARY THE EUROPEAN COMMUNITY STRATEGY

UNIT 2: mapping bananas

Monensin and Extruded Urea-Grain for Range Beef Cows

TOP TIPS Lung Cancer Update Dr Andrew Wight Consultant respiratory Physician - WUTH

Seeking and Appraising Evidence

Meaningful Use Roadmap Stage Edition Eligible Hospitals

Imaging tests allow the cancer care team to check for cancer and other problems inside the body.

P02-03 CALA Program Description Proficiency Testing Policy for Accreditation Revision 1.9 July 26, 2017

National Imaging Associates, Inc. (NIA) Frequently Asked Questions (FAQ s) For PA Health & Wellness Providers

For our protection, we require verification that you have received this notice. Therefore, please sign below.

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

Iowa Early Periodic Screening, Diagnosis and Treatment Care for Kids Program Provider Training

British Sign Language (BSL) Plan October 2018 Scottish Charity Regulator

CLINICAL MEDICAL POLICY

Immunisation and Disease Prevention Policy

Improving Treatment Rates of Cervical Precancers Detected through Visual Screening in Cameroon, West Africa.

Rush Copley Medical Center 2017 Prevention and Screening Initiatives

World Confederation for Physical Therapy Congress , May Singapore

Indirect Sales. Proof Policy. Indirect Channel. Version May Author: Credit Risk & Fraud. External version

Echocardiography Diagnostic Accuracy

Patterns of Cholesterol Distribution in the Participants of a Screening Project

Introduction Teaching Interpretation

A foot x-ray series is required only if there is pain in the midfoot zone and any one of the following:

The ECG app is not intended for use by people under 22 years old.

Transcription:

Field Epidemilgy Training Prgram Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registries FACILITATOR GUIDE

FETP Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registry Overview Participants will apply what they learned in the Hspital-Based Cancer Registry (HBCR) min-mdule and Mdule 3: Principles f Cancer Registratin t the data frm a multi-institutin HBCR in India. Participants will wrk in small grups as instructed by the Facilitatr. Objectives At the end f this exercise, participants shuld be able t wrk thrugh a sample scenari frm India t evaluate the data quality f a HBCR, describe the ccurrence f cancer in the respective area, t assess the quality f care, and t interpret infrmatin generated by HBCR Backgrund The Natinal Cancer Registry Prgramme (NCRP) has been in existence since 1982 and a permanent institute (Natinal Centre fr Disease Infrmatics and Research (NCDIR)) f the Indian Cuncil f Medical Research in 2011. The NCDIR centre is a repsitry f data frm the cllabrating cancer registries lcated in medical clleges/institutins and hspitals thrughut India. As f March 2016, there were 29 HBCRs (including all Reginal Cancer Centres). Registries use the web-based Hspital Based Cancer Registry Database Management sftware t capture relevant infrmatin (cancer patient s identificatin, diagnstic and treatment infrmatin registered in the hspital). The sftware facilitates the data cllectin and transitin t the NCRP, as well as generate quality check reprts generated by the centres r the NCRP. Updates and crrectins f the data can be perfrmed nline. HBCRs prvide individual cre data. Quality Cntrl checks, tabulatins and statistical analysis are dne at the NCDIR- NCRP, Bengaluru. Data quality The registry data underges several quality checks, bth, at the time f data entry and subsequently. Quality checks include: range, cnsistency, unlikely and family checks as per the IARC nrms (cncepts cvered in Mdule 3). All data checks are built int the Hspital Based Cancer Registry Database Management applicatin. The list f cases with pssible errrs is sent back t the respective registries fr verificatin with the riginal medical recrds and the crrectins received are updated in the registry database. (Surce: NATIONAL CENTRE FOR DISEASE INFORMATICS AND RESEARCH. NATIONAL CANCER REGISTRY PROGRAMME. Indian Cuncil f Medical Research. Cnslidated Reprt f Hspital Based Cancer Registries 2012-2014) Facilitatr Guide 1

FETP Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registry Surce: http://www.hbcrindia.rg/ Facilitatr Guide 2

Part I: Checking the quality f the data FETP Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registry The first step is t evaluate the quality f the data. Q1: Use tables 11.1, 11.3, 4.1, and 11.4 t describe the quality f the NCRP data and explain what yu bserve. TMH, Tata Memrial Hspital, Mumbai; KMIO, Kidwai Memrial Institute f Onclgy, Bangalre; CI (WIA), Cancer Institute (WIA), Chennai; RCC - TVM, Reginal Cancer Centre, Thiruvananthapuram; AMC, Assam Medical Cllege & Hspital, Dibrugarh; BBCI, Dr. B. Brah Cancer Institute, Guwahati; PGIMER, Pst Graduate Institute f Medical Educatin & Research, Chandigarh; BRAIRCH, Dr. B.R. Ambedkar Institute Rtary Cancer Hspital, AIIMS, New Delhi Table 11.1 (% f cases f unknwn age): Mst f the HBCRs d nt have any cases with age unknwn. One registry appears t pssibly have relatively mre cases with missing age (RCC- TVM). Facilitatr Guide 3

FETP Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registry TMH, Tata Memrial Hspital, Mumbai; KMIO, Kidwai Memrial Institute f Onclgy, Bangalre; CI (WIA), Cancer Institute (WIA), Chennai; RCC - TVM, Reginal Cancer Centre, Thiruvananthapuram; AMC, Assam Medical Cllege & Hspital, Dibrugarh; BBCI, Dr. B. Brah Cancer Institute, Guwahati; PGIMER, Pst Graduate Institute f Medical Educatin & Research, Chandigarh; BRAIRCH, Dr. B.R. Ambedkar Institute Rtary Cancer Hspital, AIIMS, New Delhi TMH, Tata Memrial Hspital, Mumbai; KMIO, Kidwai Memrial Institute f Onclgy, Bangalre; CI (WIA), Cancer Institute (WIA), Chennai; RCC - TVM, Reginal Cancer Centre, Thiruvananthapuram; AMC, Assam Medical Cllege & Hspital, Dibrugarh; BBCI, Dr. B. Facilitatr Guide 4

FETP Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registry Brah Cancer Institute, Guwahati; PGIMER, Pst Graduate Institute f Medical Educatin & Research, Chandigarh; BRAIRCH, Dr. B.R. Ambedkar Institute Rtary Cancer Hspital, AIIMS, New Delhi Table 11.3 (MV%) and table 4.1 (number and relative prprtin f cancers based n different methds f diagnsis): The prprtin f MV cases is high ranging frm 83.8 t 98.5% in bth sexes (Table 11.3). Accrding t the distributin f cancer cases by methd f diagnsis and sex (table 4.1), the use f imaging techniques is the secnd mst frequently used methd f diagnsis, after MV. Clinical diagnsis ccurred in 0-5.6% f the cases while the use f ther methds was rare. The higher the prprtin f MV cases the mre accurate is the cnfirmatin (as micrscpic verificatin is the mst valid basis f diagnsis f cancer). Hwever, a very high prprtin f MV cases (nearly 100% in PGMER & BRAIRCH) suggests ver-reliance in pathlgy reprts and cases diagnsis by ther means (imaging techniques, clinical diagnses) may be missed by the registry. TMH, Tata Memrial Hspital, Mumbai; KMIO, Kidwai Memrial Institute f Onclgy, Bangalre; CI (WIA), Cancer Institute (WIA), Chennai; RCC - TVM, Reginal Cancer Centre, Thiruvananthapuram; AMC, Assam Medical Cllege & Hspital, Dibrugarh; BBCI, Dr. B. Brah Cancer Institute, Guwahati; PGIMER, Pst Graduate Institute f Medical Educatin & Research, Chandigarh; BRAIRCH, Dr. B.R. Ambedkar Institute Rtary Cancer Hspital, AIIMS, New Delhi Table 11.4 (Other and Unspecified Site, O&U): The prprtin f cancers register as O&U was less than 5% in all HBCRs except TMH and BBCI, suggesting a gd diagnstics precisin. The data als suggest that re-training f registry abstractrs in the HBCRs f TMH and BBCI may be needed in rder t reduce the percentage cases registered under the O&U categry. Registry abstractrs need t diligently track these cases t the cncerned physician/ pathlgist and find the infrmatin n the exact primary site f tumr. Such errrs culd create delays and therefre affect timeliness f the infrmatin. Furthermre, the cllabratin f physicians, pathlgists, nclgists, and ther cncerned authrities t maintain gd quality recrds, and als prvide clear infrmatin abut fllw-up pst-treatment is needed t register all the cases and t fulfill the gals f the registry. Facilitatr Guide 5

FETP Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registry Q2: Based n tables 11.1 and 11.3-11.4, what can yu cnclude abut the quality f the NCRP data? The quality f the NCRP data is gd as illustrated by the lw % f cases with unknwn age, and the relatively lw % f O&U cases. Hwever, in sme registries nearly 100% f the cases were MV (PGMER & BRAIRCH) suggesting that cases diagnsis by ther means maybe missed. Learning pints: Hw t evaluate the data quality f a HBCR Interpret infrmatin generated by HBCR Part II: Describe the dimensin f cancer in the area cvered The secnd step is t use the HBCR data t describe the dimensin f cancer in the area cvered. Q3: Use Table 1.2 t list the mst frequent cancers ccurring in male and females in the respective HBCRs. Facilitatr Guide 6

FETP Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registry Table 1.2: Number (#), Relative Prprtin (%) and Rank (R) f Leading Sites f Cancer, Males * Rank nt within first ten. TMH, Tata Memrial Hspital, Mumbai; KMIO, Kidwai Memrial Institute f Onclgy, Bangalre; CI (WIA), Cancer Institute (WIA), Chennai; RCC - TVM, Reginal Cancer Centre, Thiruvananthapuram; AMC, Assam Medical Cllege & Hspital, Dibrugarh; BBCI, Dr. B. Brah Cancer Institute, Guwahati; PGIMER, Pst Graduate Institute f Medical Educatin & Research, Chandigarh; BRAIRCH, Dr. B.R. Ambedkar Institute Rtary Cancer Hspital, AIIMS, New Delhi Facilitatr Guide 7

FETP Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registry Table 1.2: Number (#), Relative Prprtin (%) and Rank (R) f Leading Sites f Cancer, Females * Rank nt within first ten TMH, Tata Memrial Hspital, Mumbai; KMIO, Kidwai Memrial Institute f Onclgy, Bangalre; CI (WIA), Cancer Institute (WIA), Chennai; RCC - TVM, Reginal Cancer Centre, Thiruvananthapuram; AMC, Assam Medical Cllege & Hspital, Dibrugarh; BBCI, Dr. B. Brah Cancer Institute, Guwahati; PGIMER, Pst Graduate Institute f Medical Educatin & Research, Chandigarh; BRAIRCH, Dr. B.R. Ambedkar Institute Rtary Cancer Hspital, AIIMS, New Delhi Facilitatr Guide 8

FETP Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registry Males: Females: In TMH, the 5 leading cancers (in ascending rder) were: muth cancer, fllwed by lung, tngue, Nn-Hdgkin s Lymphma (NHL) (5.1%) and myelid leukaemia. In KMIO, the 5 leading cancers (in ascending rder) were: esphagus, lung, hyppharynx, tngue and stmach. In CI (WIA) the 5 leading cancers (in ascending rder) were: lung (10.0%) and muth (9.7%), fllwed by stmach, tngue and esphagus. In RCC, the 5 leading cancers (in ascending rder) were: lung, muth, tngue, stmach and NHL. In AMC, the 5 leading cancers (in ascending rder) were: hyppharynx and esphagus fllwed by muth, stmach, and tngue. In BBCI, the 5 leading cancers (in ascending rder) were: esphagus, hyppharynx, lung, muth and tngue. In PGIMER, the 5 leading cancers (in ascending rder) were: lung, brain NS, esphagus, larynx and tngue. In BRAIRCH, the 5 leading cancers (in ascending rder) were: muth, lung, tngue, NHL, and brain NS. In TMH, the 5 leading cancers (in ascending rder) were: breast, cervix, vary, gallbladder and muth. In KMIO, the 5 leading cancers (in ascending rder) were: cervix, breast, muth, vary, and esphagus. In CI (WIA), the 5 leading cancers (in ascending rder) were: breast, cervix, vary, stmach, and muth. In RCC, the 5 leading cancers (in ascending rder) were: breast, thyrid, cervix, vary, and muth. In AMC, the 5 leading cancers (in ascending rder) were: breast, gallbladder, cervix, esphagus and vary. In BBCI, the 5 leading cancers (in ascending rder) were: breast, gallbladder, cervix, esphagus, and muth. In PGIMER, the 5 leading cancers (in ascending rder) were: breast, cervix, vary, gallbladder, and esphagus. In BRAIRCH, the 5 leading cancers (in ascending rder) were: breast, cervix, vary, gallbladder, and NHL. The cmmn theme seems t be high frequency f tbacc related cancer in bth sexes. This infrmatin might be useful t infrm the cancer cntrl prgram in the respective institutin, if in place. Facilitatr Guide 9

FETP Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registry PART III: HBCR data used t assess the quality f care Q4: Use Table 5.1 t describe the different aspects in the management f cancer patients in the registries f the NCRP. The NCRP defines the fllwing 4 categries: Prir Treatment Only (Prir Tmt. Only): Thse patients wh have received sme r cmplete cancer directed treatment befre registratin and have nt received any further treatment at the reprting institutin. Prir Treatment & Treatment at Reprting Institutin (Prir & Tmt. at RI): These are patients wh have received cancer directed treatment prir t registratin and have received further treatment at the Reprting Institutin (RI). Treatment Only at Reprting Institutin (Tmt. nly at RI): Patients wh have cme fr the first time t the reprting institutin with r withut a cnfirmed diagnsis f malignancy and have nt received any cancer directed treatment earlier and received cmplete cancer directed treatment at the reprting institutin. N Cancer Directed Treatment (N CDT): This grup includes patients wh have neither received nr accepted any treatment. It als includes the patients wh have nt cmpleted any frm f treatment and where the treatment status is unknwn. TMH, Tata Memrial Hspital, Mumbai; KMIO, Kidwai Memrial Institute f Onclgy, Bangalre; CI (WIA), Cancer Institute (WIA), Chennai; RCC - TVM, Reginal Cancer Centre, Thiruvananthapuram; AMC, Assam Medical Cllege & Hspital, Dibrugarh; BBCI, Dr. B. Brah Cancer Institute, Guwahati; PGIMER, Pst Graduate Institute f Medical Educatin & Research, Chandigarh; BRAIRCH, Dr. B.R. Ambedkar Institute Rtary Cancer Hspital, AIIMS, New Delhi Facilitatr Guide 10

FETP Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registry Apprximately 5-11% f the patients received sme r cmplete cancer directed treatment befre registratin and have nt received any further treatment at the reprting institutin (Prir Tmt. Only), except fr AMC with less than 1% f the patients and BRAIRCH with 15.1% f the males and 18.9% f the females receiving sme r cmplete cancer directed treatment befre registratin and have nt received any further treatment at the reprting institutin. Apprximately 3-15% f the patients f patients received cancer directed treatment prir t registratin and have received further treatment at the reprting institutin (Prir and Tmt. at RI). Mst patients came fr the first time t the reprting institutin with r withut a cnfirmed diagnsis f malignancy and have nt received any cancer directed treatment earlier and received cmplete cancer directed treatment at the reprting institutin (Tmt. nly at RI). Abut 30-50% f the patients at the reprting institutin neither received nr accepted any treatment r cmpleted any frm f treatment r the treatment status is unknwn (N CDT). AMC, PGIMER, and RCC - TVM had the highest frequency f "TmT nly at RI" categry and a lwer prprtin in the N CDT categry as cmpared t the ther institutins. Q5: Use table 7.1-7.2 t describe patient's access t quality f care TMH, Tata Memrial Hspital, Mumbai; KMIO, Kidwai Memrial Institute f Onclgy, Bangalre; CI (WIA), Cancer Institute (WIA), Chennai; RCC - TVM, Reginal Cancer Centre, Thiruvananthapuram; AMC, Assam Medical Cllege & Hspital, Dibrugarh; BBCI, Dr. B. Brah Cancer Institute, Guwahati; PGIMER, Pst Graduate Institute f Medical Educatin & Research, Chandigarh; BRAIRCH, Dr. B.R. Ambedkar Institute Rtary Cancer Hspital, AIIMS, New Delhi In all the HBCRs the rati between the number f prcedures and the number f patients treated was in the range f 1.3 and 2.0. CI (WIA) perfrmed 2-prcedures per patient treated. Facilitatr Guide 11

FETP Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registry Table 7.2: Number (#) and Relative Prprtin (%) f Patients accrding t Type f Treatment Given TMH, Tata Memrial Hspital, Mumbai; KMIO, Kidwai Memrial Institute f Onclgy, Bangalre; CI (WIA), Cancer Institute (WIA), Chennai; RCC - TVM, Reginal Cancer Centre, Thiruvananthapuram; AMC, Assam Medical Cllege & Hspital, Dibrugarh; BBCI, Dr. B. Brah Cancer Institute, Guwahati; PGIMER, Pst Graduate Institute f Medical Educatin & Research, Chandigarh; BRAIRCH, Dr. B.R. Ambedkar Institute Rtary Cancer Hspital, AIIMS, New Delhi Facilitatr Guide 12

FETP Cancer Curriculum: Principles f Cancer Registries Case Study: Hspital-Based Cancer Registry Amng patients treated: Raditherapy was the predminant frm f treatment mdality in BBCI in bth males and females. Chemtherapy was the mst frequent frm f treatment in males in BRAIRCH, RCC-TVM and CI (WIA) and in females in RCC-TVM, BRAIRCH and PGIMER. Surgery was perfrmed mre frequently in females in AMC than in any ther institutin. Mdality f treatment: Single mdality f therapy ranged between 44.0% in CI (WIA) t 67.2% in AMC in males and frm 27.1% in CI (WIA) t 66.3% in AMC in females. Males: Single therapy was mre frequent than cmbined therapy in all HBCRs, except CI (WIA) where cmbined therapy was mre frequent. Females: Cmbined therapy was mre frequent in TMH, KMIO, CI (WIA) and RCC-TVM while single therapy was mre frequent in AMC, BBCI, PGIMER and BRAIRCH. Learning pints: Hw t asses patient care, prvide an idea f the patterns f cancer in the area, help plan hspital facilities. Interpret infrmatin generated by HBCR. Facilitatr Guide 13